Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,664
Total Claims
$684K
Drug Cost
753
Beneficiaries
$908
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-36%
Opioid rate vs peers
1.4% vs 2.2% avg
-36%
Cost per patient vs peers
$908 vs $1,411 avg
-17%
Brand preference vs peers
8.8% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.4%
Opioid Rate
153
Opioid Claims
$2,343
Opioid Cost
7.8%
Long-Acting Rate
Brand vs Generic
Brand: 930 claims · $497K
Generic: 9,663 claims · $185K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 107 | $96K |
| Dulaglutide | 56 | $60K |
| Insulin Glargine,hum.Rec.Anlog | 64 | $48K |
| Liraglutide | 21 | $38K |
| Rivaroxaban | 32 | $30K |
| Empagliflozin | 14 | $14K |
| Semaglutide | 11 | $13K |
| Dapagliflozin Propanediol | 13 | $12K |
| Levothyroxine Sodium | 639 | $11K |
| Liraglutide | 11 | $9,409 |
| Insulin Lispro | 11 | $7,873 |
| Fluticasone Propion/Salmeterol | 37 | $7,133 |
| Gabapentin | 407 | $6,870 |
| Insulin Degludec | 11 | $6,553 |
| Atorvastatin Calcium | 470 | $6,502 |
Prescribing Profile
Patient Profile
77
Avg Age
50%
Female
1.10
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About